3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Postoperative Cognitive Complications
1
Neoplasms
1
Malnutrition
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Frailty
1
Emergence Delirium
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Fulvestrant
64
Letrozole
54
Paclitaxel
49
Trastuzumab
41
pembrolizumab
40
ribociclib
37
Specimen Handling
37
palbociclib
36
Capecitabine
34
Anastrozole
34
Carboplatin
33
Tamoxifen
32
exemestane
30
pertuzumab
28
abemaciclib
28
Magnetic Resonance Spectroscopy
26
Cyclophosphamide
26
trastuzumab deruxtecan
24
Surveys and Questionnaires
21
Biopsy
19
Radiotherapy
18
olaparib
17
Blood Specimen Collection
17
Standard of Care
16
Docetaxel
16
Taxes
14
Mastectomy, Segmental
14
eribulin
13
elacestrant
13
Methods
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Control Groups
×
90 days
×
Clear all
NCT04816006
2026-05-20
BRAIN
Mayo Clinic
Phase NA
Recruiting
160 enrolled